GRAPPA 2019 Project Report

Niti Goel^1,2, Laura C Coates^3,4, Gabriele De Marco^3,4+11

• ¹From the Duke University School of Medicine, Durham, North Carolina, USA; Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; University of Toronto and Women's College Hospital, Toronto, Ontario, Canada; Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Bradford Hospitals UK NHS Foundation Trust, Bradford, UK; Duke-National University of Singapore (NUS) Medical School, Singapore; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; University of Alberta, Edmonton, Alberta, Canada; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; University of Copenhagen and National Hospital (Rigshospitalet), Copenhagen, Denmark; Our Lady's Hospice & Care Services, Dublin, Ireland; Charité-Universitätsmedizin Berlin, and German Rheumatism Research Centre, Berlin, Germany; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; University of Toronto, Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada. agwngw1@gmail.com.+3